Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 24 results.
User Information
Export Records
  1. 1.   Xenobiotic-metabolizing gene variants, pesticide use, and the risk of prostate cancer
  2. Koutros, S.; Andreotti, G.; Berndt, S. I.; Barry, K. H.; Lubin, J. H.; Hoppin, J. A.; Kamel, F.; Sandler, D. P.; Burdette, L. A.; Yuenger, J.; Yeager, M.; Alavanja, M. C. R.; Freeman, L. E. B.
  3. Pharmacogenetics and Genomics. 2011, Oct; 21(10): 615-623.
  1. 2.   Population pharmacokinetic analysis of sorafenib in patients with solid tumours
  2. Jain, L.; Woo, S.; Gardner, E. R.; Dahut, W. L.; Kohn, E. C.; Kummar, S.; Mould, D. R.; Giaccone, G.; Yarchoan, R.; Venitz, J.; Figg, W. D.
  3. British Journal of Clinical Pharmacology. 2011, Aug; 72(2): 294-305.
  1. 3.   Isolation and Characterization of the CYP2D6 Gene in Felidae with Comparison to Other Mammals
  2. Schenekar, T.; Winkler, K. A.; Troyer, J. L.; Weiss, S.
  3. Journal of Molecular Evolution. 2011, Feb; 72(2): 222-231.
  1. 4.   A novel synthetic analogue of a constituent of Isodon excisus inhibits transcription of CYP1A1,-1A2 and-1B1 by preventing activation of the aryl hydrocarbon receptor
  2. Sienkiewicz, P.; Ciolino, H. P.; Leslie, B. J.; Hergenrother, P. J.; Singletary, K.; Yeh, G. C.
  3. Carcinogenesis. 2007, May; 28(5): 1052-1057.
  1. 5.   Inactivation of oxidized and S-nitrosylated mitochondrial proteins in alcoholic fatty liver of rats
  2. Moon, K. H.; Hood, B. L.; Kim, B. J.; Hardwick, J. P.; Conrads, T. P.; Veenstra, T. D.; Song, B. Y. J.
  3. Hepatology. 2006, Nov; 44(5): 1218-1230.
  1. 6.   Modeling dioxygen binding to the non-heme iron-containing enzymes
  2. Nemukhin, A. V.; Grigorenko, B. L.; Topol, I. A.; Burt, S. K.
  3. International Journal of Quantum Chemistry. 2006, Aug; 106(10): 2184-2190.
  1. 7.   On the nature of oxoiron (IV) intermediate in dioxygen activation by non-heme enzymes
  2. Nemukhin, A. V.; Topol, I. A.; Cachau, R. E.; Burt, S. K.
  3. Theoretical Chemistry Accounts. 2006, MAY; 115(5): 348-353.
  1. 8.   Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients
  2. Lepper, E. R.; Baker, S. D.; Permenter, M.; Ries, N.; van Schaik, R. H. N.; Schenk, P. W.; Price, D. K.; Ahn, D.; Smith, N. F.; Cusatis, G.; Ingersoll, R. G.; Bates, S. E.; Mathijssen, R. H. J.; Verweij, J.; Figg, W. D.; Sparreboom, A.
  3. Clinical Cancer Research. 2005, OCT 15; 11(20): 7398-7404.
  1. 9.   The CYP2E1-humanized transgenic mouse: Role of CYP2E1 in acetaminophen hepatotoxicity
  2. Cheung, C.; Yu, A. M.; Ward, J. M.; Krausz, K. W.; Akiyama, T. E.; Feigenbaum, L.; Gonzalez, F. J.
  3. Drug Metabolism and Disposition. 2005, MAR; 33(3): 449-457.
  1. 10.   Enhanced acetaminophen toxicity by activation of the pregnane X receptor
  2. Guo, G. L.; Moffit, J. S.; Ward, J. M.; Aleksunes, L. A.; Slitt, A. L.; Kliewer, S. A.; Manautou, J. E.; Gonzalez, F. J.
  3. Toxicological Sciences. 2004, DEC; 82(2): 374-380.
  1. 11.   The experimental antitumor agents Phortress and Doxorubicin are equiactive against human-derived breast carcinoma xenograft models
  2. Fichtner, I.; Monks, A.; Hose, C.; Stevens, M. F. G.; Bradshaw, T. D.
  3. Breast Cancer Research and Treatment. 2004, SEP; 87(1): 97-107.
  1. 12.   Glycine N-methyltransferase tumor susceptibility gene in the benzo(a)pyrene-detoxification pathway
  2. Chen, S. Y.; Lin, J. R. V.; Darbha, R.; Lin, P. P.; Liu, T. Y.; Chen, Y. M. A.
  3. Cancer Research. 2004 64(10): 3617-3623.
  1. 13.   The drug salicylamide is an antagonist of the aryl hydrocarbon receptor that inhibits signal transduction induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin
  2. MacDonald, C. J.; Ciolino, H. P.; Yeh, G. C.
  3. Cancer Research. 2004 64(1): 429-434.
  1. 14.   Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero
  2. Waalkes, M. P.; Liu, J.; Chen, H.; Xie, Y. X.; Achanzar, W. E.; Zhou, Y. S.; Cheng, M. L.; Diwan, B. A.
  3. Journal of the National Cancer Institute. 2004 96(6): 466-474.
  1. 15.   Aryl hydrocarbon receptor activation of an antitumor aminoflavone: Basis of selective toxicity for MCF-7 breast tumor cells
  2. Loaiza-Perez, A. I.; Kenney, S.; Boswell, J.; Hollingshead, M.; Alley, M. C.; Hose, C.; Ciolino, H. P.; Yeh, G. C.; Trepel, J. B.; Vistica, D. T.; Sausville, E. A.
  3. Molecular Cancer Therapeutics. 2004 3(6): 715-725.
  1. 16.   Induction of CYP1A1 in tumor cells by the antitumor agent 2-[4- amino-3-methylphenyl]-5-fluoro-benzothiazole: A potential surrogate marker for patient sensitivity
  2. Hose, C. D.; Hollingshead, M.; Sausville, E. A.; Monks, A.
  3. Molecular Cancer Therapeutics. 2003 2(12): 1265-1272.
  1. 17.   Resistance of MCF-7 cells to dimethylbenz(a)anthracene-induced apoptosis is due to reduced CYP1A1 expression
  2. Ciolino, H. P.; Dankwah, M.; Yeh, G. C.
  3. International Journal of Oncology. 2002 21(2): 385-391.
  1. 18.   The effects of resveratrol on CYP1A1 expression and aryl hydrocarbon receptor function in vitro
  2. Ciolino, H. P.; Yeh, G. C.
  3. Nutrition and Cancer Prevention. 2001; 492 : 183-193.
  1. 19.   P450 enzyme expression patterns in the NCI human tumor cell line panel
  2. Yu, L. J.; Matias, J.; Scudiero, D. A.; Hite, K. M.; Monks, A.; Sausville, E. A.; Waxman, D. J.
  3. Drug Metabolism and Disposition. 2001 29(3): 304-312.
  1. 20.   DNA adducts of 2-amino-3-methylimidazo
  2. Josyula, S.; Lu, L. J. W.; Salazar, J. J.; Nerurkar, P. V.; Jones, A. B.; Grady, J. J.; Snyderwine, E. G.; Anderson, L. M.
  3. Toxicology and Applied Pharmacology. 2000 166(3): 151-160.
  1. 21.   Age-related alterations in P-32-postlabeled DNA adducts in livers of mice infected with the tumorigenic bacterial pathogen, Helicobacter hepaticus
  2. Josyula, S.; Schut, H. A. J.; Diwan, B. A.; Anver, M. R.; Anderson, L. M.
  3. International Journal of Oncology. 2000 17(4): 811-818.
  1. 22.   Comparative Pharmacodynamics of Cyp2b Induction By Ddt, Dde, and Ddd in Male Rat Liver and Cultured Rat Hepatocytes
  2. Nims, R. W.; Lubet, R. A.; Fox, S. D.; Jones, C. R.; Thomas, P. E.; Reddy, A. B.; Kocarek, T. A.
  3. Journal of Toxicology and Environmental Health. 1998 53(6): 455-477.
  1. 23.   Cyp2e1 Genetic Polymorphisms and Risk of Nasopharyngeal Carcinoma in Taiwan
  2. Hildesheim, A.; Anderson, L. M.; Chen, C. J.; Cheng, Y. J.; Brinton, L. A.; Daly, A. K.; Reed, C. D.; Chen, I. H.; Caporaso, N. E.; Hsu, M. M.; Chen, J. Y.; Idle, J. R.; Hoover, R. N.; Yang, C. S.; Chhabra, S. K.
  3. Journal of the National Cancer Institute. 1997 89(16): 1207-1212.
  1. 24.   Tgf-Alpha Sustains Clonal Expansion By Promoter-Dependent, Chemically Initiated Rat Hepatocytes
  2. Kaufmann, W. K.; Byrd, L. L.; Palmieri, D.; Nims, R. W.; Rice, J. M.
  3. Carcinogenesis. 1997 18(7): 1381-1387.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel